Compounds > atomoxetine hydrochloride
Page last updated: 2024-08-23

atomoxetine hydrochloride and Nausea

atomoxetine hydrochloride has been researched along with Nausea in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bardenstein, LM; Jarkova, NB; Kozlova, IA; Martenyi, F; Maslova, OI; Neznanov, NG; Petrukhin, AS; Soldatenkova, VO; Sukchotina, NK; Yarosh, AA; Zavadenko, NN; Zykov, VP1
Harpin, V; Jamdar, S; Poole, L; Prasad, S; Puvanendran, K; Zeitlin, H1
Allen, AJ; Bangs, ME; Bartky, EJ; Busner, J; Carlson, C; Duesenberg, DA; Emslie, GJ; Harshawat, P; Kaplan, SL; Quintana, H; Ramsey, JL; Spencer, TJ; Sumner, CR1
Allen, AJ; Chou, MC; Chou, WJ; Gau, SS; Huang, YS; Lee, P; Shang, CY; Soong, WT; Tseng, WL1

Trials

4 trial(s) available for atomoxetine hydrochloride and Nausea

ArticleYear
Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia.
    European child & adolescent psychiatry, 2010, Volume: 19, Issue:1

    Topics: Abdominal Pain; Adolescent; Adrenergic Uptake Inhibitors; Analysis of Variance; Anorexia; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Double-Blind Method; Female; Humans; Nausea; Parents; Propylamines; Psychiatric Status Rating Scales; Russia; Sleep; Treatment Outcome; Weight Loss

2010
A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD).
    Current medical research and opinion, 2007, Volume: 23, Issue:2

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Drug Therapy, Combination; Female; Headache; Humans; Male; Methylphenidate; Nausea; Propylamines; Prospective Studies; Severity of Illness Index; Treatment Outcome

2007
Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression.
    Journal of child and adolescent psychopharmacology, 2007, Volume: 17, Issue:4

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Nausea; Propylamines; Psychiatric Status Rating Scales; Severity of Illness Index

2007
A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine in Taiwanese children and adolescents with attention-deficit/hyperactivity disorder.
    Journal of child and adolescent psychopharmacology, 2007, Volume: 17, Issue:4

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Appetite; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Double-Blind Method; Drug Administration Schedule; Faculty; Female; Humans; Male; Nausea; Parents; Propylamines; Psychiatric Status Rating Scales; Severity of Illness Index; Taiwan; Treatment Outcome

2007

Other Studies

1 other study(ies) available for atomoxetine hydrochloride and Nausea

ArticleYear
Atomoxetine (strattera) for ADHD.
    The Medical letter on drugs and therapeutics, 2003, Feb-03, Volume: 45, Issue:1149

    Topics: Adult; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Dose-Response Relationship, Drug; Drug Interactions; Humans; Intestinal Absorption; Nausea; Propylamines; Randomized Controlled Trials as Topic

2003